Specifications
- Purity
- ≥98% (NMR)
- Appearance
- White to yellow solid
- Identity
- 1H-NMR
Properties
- Solvents
- Soluble in DMSO (20mg/ml). Insoluble in water.
- Melting Point
- 95 - 102 °C
Category: API's & Intermediates
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Pemafibrate is a peroxisome proliferator-activated receptor α agonist (PPARα EC50 = 1nM for transcriptional activity). Pemafibrate is selective for PPARα over PPARδ and PPARγ (EC50 = 2300 and 1000nM, respectively). PPARα is a transcription factor that is essential for regulation of lipid homeostasis and glucose metabolism and has been implicated in inflammation. Pemafibrate was associated with the inhibition of inflammatory responses without affecting cell proliferation or angiogenesis, and subsequently may induce an anti-atherosclerotic effect.
| Synonyms | K877, (R)-K 13675, CS-2768 |
|---|---|
| Purity | ≥98% (NMR) |
| Appearance | White to yellow solid |
| CAS-Number | 848259-27-8 |
| Molecular Formula | C28H30N2O6 |
| Molecular Weight | 490.56 |
| Identity | 1H-NMR |
| Solvents | Soluble in DMSO (20mg/ml). Insoluble in water. |
| Melting Point | 95 – 102 °C |
| Smiles | CC[C@H](C(O)=O)OC1=CC(CN(C2=NC3=C(C=CC=C3)O2)CCCOC4=CC=C(OC)C=C4)=CC=C1 |
| InChi Key | ZHKNLJLMDFQVHJ-RUZDIDTESA-N |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | +4°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at +4°C. |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| GHS Symbol | GHS07 |
| Signal word | Warning |
| Transportation | Not dangerous goods |
| References | (1) K. Kitajima, et al.; Atheroscl. 203, 75 (2009), (2) N. Hennuyer, et al.; Atheroscl. 249, 200 (2016), (3) Y. Honda, et al.; Sci. Rep. 7, 42477 (2017), (4) N. Ferri, et al.; Expert. Opin. Investig. Drugs 26, 593 (2017), (5) J.C. Fruchart; Cardiovasc. Diabetol. 16, 124 (2017), (6) Y. Yamamoto, et al.; Biochem. Biophys. Res. Commun. 499, 239 (2018), (7) J.C. Fruchart & R.D. Santos; Curr. Opin. Lipidol. 30, 419 (2019), (8) Y. Sasaki, et al.; Sci. Rep. 10, 7818 (2020) |
| InChi | InChI=1S/C28H30N2O6/c1-3-25(27(31)32)35-23-9-6-8-20(18-23)19-30(28-29-24-10-4-5-11-26(24)36-28)16-7-17-34-22-14-12-21(33-2)13-15-22/h4-6,8-15,18,25H,3,7,16-17,19H2,1-2H3,(H,31,32)/t25-/m1/s1 |
| Quantity | 10 mg, 50 mg, Bulk |

Pioglitazone hydrochloride